1.
Nat Biotechnol
; 39(2): 135-143, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-1383115
Subject(s)
Biological Products/therapeutic use , Antibodies, Monoclonal/therapeutic use , Cell- and Tissue-Based Therapy , Drug Approval , Humans , Immunoconjugates/therapeutic use , Internationality , Rare Diseases/drug therapy , United States , United States Food and Drug Administration , COVID-19 Drug Treatment
2.
Pain Med
; 22(12): 2779-2782, 2021 12 11.
Article
in English
| MEDLINE | ID: covidwho-1345740
3.
Nat Biotechnol
; 38(5): 523-532, 2020 05.
Article
in English
| MEDLINE | ID: covidwho-712749
Subject(s)
Antiviral Agents/classification , Coronavirus Infections/drug therapy , Drug Development/economics , Pneumonia, Viral/drug therapy , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , COVID-19 , Coronavirus Infections/prevention & control , Drug Repositioning , Humans , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Time Factors
4.
Mil Med
; 186(3-4): 93-94, 2021 02 26.
Article
in English
| MEDLINE | ID: covidwho-964574